Mandy van Brakel

Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient

Imran Siddiqui, Marco Erreni, Mandy van Brakel et al. · Journal for ImmunoTherapy of Cancer · 2016 · 112 citations · Full text

Life Sciences, Immunology, Oncology +17

CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab

André Kunert, Edwin A. Basak, Daan P. Hurkmans et al. · Journal for ImmunoTherapy of Cancer · 2019 · 57 citations · Full text

Medicine, Cancer Biology, Oncology +17

TCRs Genetically Linked to CD28 and CD3ε Do Not Mispair with Endogenous TCR Chains and Mediate Enhanced T Cell Persistence and Anti-Melanoma Activity

Coen Govers, Zsolt Sebestyén, Mandy van Brakel et al. · The Journal of Immunology · 2014 · 46 citations · Full text

Life Sciences, Cell Biology, Immunology +17

TCR Gene Transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 Epitopes as Melanoma-Specific Immune Targets

Trudy Straetemans, Mandy van Brakel, Sabine van Steenbergen et al. · Clinical and Developmental Immunology · 2012 · 41 citations · Full text

Life Sciences, Immunology, Oncology +17

Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy

Mirjam de With, Daan P. Hurkmans, Esther Oomen‐de Hoop et al. · Cancers · 2021 · 40 citations · Full text

Life Sciences, Genetics, Oncology +17